Abraxane (Celgene Oncology) success in Phase II study for Metastatic Melanoma - 03-Oct-2012
A Phase III, randomized, international study (CA033) reported for Abraxane (paclitaxel protein-bound particles for injectable suspension) (albumin-bound), from Celgene Oncology, in chemotherapy-naïve patients with Metastatic Melanoma. In the study, the primary endpoint was met with patients receiving Abraxane demonstrating a statistically significant improvement in progression-free survival compared to patients receiving dacarbazine (DTIC) chemotherapy. The safety profile of Abraxane observed in the CA033 study is consistent with other Abraxane pivotal clinical trials. Data from this study will be presented at the Society for Melanoma Research (SMR) Congress 2012 in Los Angeles in November 2012.
Related News
GSK files at EMA trametinib (monotherapy) and in combination with dabrafenib for Metastatic Melanoma
GSK initiates Phase III study of combination dabrafenib and trametinib for Melanoma
NICE recommends Yervoy (BMS) and Zelboraf (Roche) for Melanoma
Updated results in Phase III trial of Abraxane (Celgene Oncology) for patients with Metastatic Melanoma
Abraxane (Celgene Oncology) success in Phase II study for Metastatic Melanoma
Glaxo Smith Kline files NDA and MAA for dabrafenib in Metastatic Melanoma patients
GSK files trametinib at the FDA for Metastatic Melanoma
Study shows positive results with dabrafenib (Glaxo Smith Kline) in Melanoma patients
Related Oncology Information
Oncology Clinical Guidelines
Familial breast cancer: The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care
NICEProstate cancer: diagnosis and treatment
NICEOncology Clinical Trials
Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer
Clinicaltrials.gov 08 April 2013Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy (CONKO-007)
Clinicaltrials.gov 04 April 2013Oncology Medical Journal Abstracts
Bone mass density, fracture history, self-reported osteoporosis as proxy variables for estrogen and the risk of non-small-cell lung cancer—A population based cohort study, the HUNT study: Are proxy variables friends or faults?
Lung Cancer 24 April 2013Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis
Lung Cancer 22 April 2013Oncology Medical Apps
CCO Oncology inPractice
Free
Cancer Signs and Symptoms
Free
Related Oncology Drugs
- VINBLASTINE SULPHATE 1 MG/ML INJECTION
- EFUDIX CREAM
- GLIVEC
- LEUKERAN TABLETS 2 MG
- GEMCITABINE 200 MG POWDER FOR SOLUTION FOR INFUSION / GEMCITABINE 1 G POWDER FOR SOLUTION FOR INFUSION / GEMCITABINE 2 G POWDER FOR SOLUTION FOR INFUSION
- HYCAMTIN 1MG AND 4MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- TAXOTERE 80MG/4ML CONCENTRATE FOR SOLUTION FOR INFUSION
- CARDIOXANE 500MG POWDER FOR SOLUTION FOR INFUSION
- ETOPOPHOS 100MG POWDER FOR SOLUTION FOR INJECTION
- BICALUTAMIDE 150MG FILM-COATED TABLETS
- ARIMIDEX 1MG FILM-COATED TABLET
- HALAVEN 0.44 MG/ML SOLUTION FOR INJECTION
- MITOMYCIN C
- UFTORAL HARD CAPSULES
- FLUDARA ORAL 10 MG FILM-COATED TABLET
- EVOLTRA 1MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- VINCRISTINE SULPHATE 1 MG/ML INJECTION
- FARESTON
- ZOLADEX
- ZALTRAP 25MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- MITOXANTRONE (MITOZANTRONE) 2 MG/ML STERILE CONCENTRATE
- PROSTAP 3 LEUPRORELIN ACETATE DEPOT INJECTION 11.25MG
- ROFERON-A 18MIU/0.6ML CARTRIDGE
- ONKOTRONE INJECTION
- TEPADINA 100 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- MABTHERA 100MG AND 500MG CONCENTRATE FOR SOLUTION FOR INFUSION
- ELOXATIN 5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- VOTRIENT 200 MG FILM-COATED TABLETS
- CARBOPLATIN 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- SUTENT 12.5MG, 25MG, 37.5MG AND 50MG HARD CAPSULES
- ZAVEDOS
- MEGACE 160 MG TABLETS
- TAMOFEN (CARCINOMA)
- VEPESID SOFT CAPSULES 50 MG AND 100 MG
- ROFERON-A PRE-FILLED SYRINGE
- ATRIANCE 5 MG/ML SOLUTION FOR INFUSION
- CAELYX 2MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- CAMPTO 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- KYTRIL TABLETS 1MG AND 2MG
- FASLODEX 250 MG SOLUTION FOR INJECTION
- XAGRID 0.5MG HARD CAPSULE
- GLIADEL 7.7MG IMPLANT
- SOLTAMOX
- CYTARABINE INJECTION SOLUTION 20MG/ML AND 100MG/ML
- ESTRACYT CAPSULES
- TOPOTECAN 4 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- LEVOFOLINIC ACID 50 MG/ML SOLUTION FOR INJECTION OR INFUSION
- CYPROSTAT 100MG
- TAXCEUS 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- UTOVLAN
- FIRMAGON 80MG INJECTION
- TAXOL
- MYOCET
- LEUSTAT INJECTION
- JEVTANA
- PROSTAP SR
- TAXOTERE 20MG/1ML CONCENTRATE FOR SOLUTION FOR INFUSION
- VELCADE 3.5 MG POWDER FOR SOLUTION FOR INJECTION.
- PHOTOFRIN
- FIRMAGON 120MG INJECTION
- FEMARA
- YONDELIS SOLUTION FOR INFUSION.
- NAVELBINE 10 MG / ML CONCENTRATE FOR SOLUTION FOR INFUSION
- SPRYCEL 20MG, 50MG, 80MG, 100MG AND 140MG FILM COATED TABLETS
- PROSTAP SR DCS
- MAXTREX TABLETS 2.5 MG
- VOTRIENT 200 MG AND 400 MG FILM COATED TABLETS
- VOTRIENT 200 MG FILM-COATED TABLETS
- NASTROSA 1MG FILM-COATED TABLETS
- DACARBAZINE 100MG, 200MG, 500MG, 1000MG
- CYCLOPHOSPHAMIDE 50 TABLETS
- TEMODAL CAPSULES
- CASODEX 50 MG FILM-COATED TABLETS
- FLUOROURACIL 25 MG/ML INJECTION
- PROVERA TABLETS 100 MG
- AROMASIN
- GEMZAR 200MG POWDER FOR SOLUTION FOR INFUSION, GEMZAR 1000MG POWDER FOR SOLUTION FOR INFUSION
- AVASTIN 25MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- PARAPLATIN
- TAXOTERE 160MG/8ML CONCENTRATE FOR SOLUTION FOR INFUSION
- REVLIMID
- PROLEUKIN
- ERWINASE
- IRESSA 250MG FILM-COATED TABLETS
- CASODEX 150 MG FILM-COATED TABLETS.
- CYPROSTAT 50MG
- HYCAMTIN 0.25MG AND 1 MG HARD CAPSULE
- MAXTREX TABLETS 10 MG
- GRANISETRON
- PROCARBAZINE CAPSULES 50MG
- ONCOTICE
- ERBITUX 5MG/ML SOLUTION FOR INFUSION
- TASIGNA 200 MG HARD CAPSULES
- NIPENT 10 MG POWDER FOR SOLUTION FOR INJECTION, POWDER FOR SOLUTION FOR INFUSION
- HYDREA 500 MG HARD CAPSULES
- NEXAVAR 200MG FILM-COATED TABLETS
- PROSTAP 3 DCS
- DAUNOXOME INJECTION (LIPOSOMAL DAUNORUBICIN)
- XALUPRINE
- PERJETA 420 MG CONCENTRATE FOR SOLUTION FOR INFUSION
- TARCEVA 25MG, 100MG AND 150MG FILM-COATED TABLETS
- TYVERB
- DOXORUBICIN 2MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION
- BICALUTAMIDE 50MG FILM-COATED TABLETS
- TOMUDEX
- PHARMORUBICIN
- NOVGOS
- XELODA 150MG AND 500MG FILM-COATED TABLETS
- HERCEPTIN 150MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
- TESTOSTERONE ENANTATE AMPOULES
- ISOVORIN
- VESANOID 10MG SOFT CAPSULES
Advert for Healthcare Professionals only